• Je něco špatně v tomto záznamu ?

Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model

MWJ. Wentink, T. Kalina, M. Perez-Andres, L. Del Pino Molina, H. IJspeert, FG. Kavelaars, AC. Lankester, Q. Lecrevisse, JJM. van Dongen, A. Orfao, M. van der Burg,

. 2019 ; 10 (-) : 2680. [pub] 20191126

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028742

B-cell precursors (BCP) arise from hematopoietic stem cells in bone marrow (BM). Identification and characterization of the different BCP subsets has contributed to the understanding of normal B-cell development. BCP first rearrange their immunoglobulin (Ig) heavy chain (IGH) genes to form the pre-B-cell receptor (pre-BCR) complex together with surrogate light chains. Appropriate signaling via this pre-BCR complex is followed by rearrangement of the Ig light chain genes, resulting in the formation, and selection of functional BCR molecules. Consecutive production, expression, and functional selection of the pre-BCR and BCR complexes guide the BCP differentiation process that coincides with corresponding immunophenotypic changes. We studied BCP differentiation in human BM samples from healthy controls and patients with a known genetic defect in V(D)J recombination or pre-BCR signaling to unravel normal immunophenotypic changes and to determine the effect of differentiation blocks caused by the specific genetic defects. Accordingly, we designed a 10-color antibody panel to study human BCP development in BM by flow cytometry, which allows identification of classical preB-I, preB-II, and mature B-cells as defined via BCR-related markers with further characterization by additional markers. We observed heterogeneous phenotypes associated with more than one B-cell maturation pathway, particularly for the preB-I and preB-II stages in which V(D)J recombination takes place, with asynchronous marker expression patterns. Next Generation Sequencing of complete IGH gene rearrangements in sorted BCP subsets unraveled their rearrangement status, indicating that BCP differentiation does not follow a single linear pathway. In conclusion, B-cell development in human BM is not a linear process, but a rather complex network of parallel pathways dictated by V(D)J-recombination-driven checkpoints and pre-BCR/BCR mediated-signaling occurring during B-cell production and selection. It can also be described as asynchronous, because precursor B-cells do not differentiate as full population between the different stages, but rather transit as a continuum, which seems influenced (in part) by V-D-J recombination-driven checkpoints.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028742
003      
CZ-PrNML
005      
20210114154935.0
007      
ta
008      
210105s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2019.02680 $2 doi
035    __
$a (PubMed)31849931
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Wentink, Marjolein W J $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
245    10
$a Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model / $c MWJ. Wentink, T. Kalina, M. Perez-Andres, L. Del Pino Molina, H. IJspeert, FG. Kavelaars, AC. Lankester, Q. Lecrevisse, JJM. van Dongen, A. Orfao, M. van der Burg,
520    9_
$a B-cell precursors (BCP) arise from hematopoietic stem cells in bone marrow (BM). Identification and characterization of the different BCP subsets has contributed to the understanding of normal B-cell development. BCP first rearrange their immunoglobulin (Ig) heavy chain (IGH) genes to form the pre-B-cell receptor (pre-BCR) complex together with surrogate light chains. Appropriate signaling via this pre-BCR complex is followed by rearrangement of the Ig light chain genes, resulting in the formation, and selection of functional BCR molecules. Consecutive production, expression, and functional selection of the pre-BCR and BCR complexes guide the BCP differentiation process that coincides with corresponding immunophenotypic changes. We studied BCP differentiation in human BM samples from healthy controls and patients with a known genetic defect in V(D)J recombination or pre-BCR signaling to unravel normal immunophenotypic changes and to determine the effect of differentiation blocks caused by the specific genetic defects. Accordingly, we designed a 10-color antibody panel to study human BCP development in BM by flow cytometry, which allows identification of classical preB-I, preB-II, and mature B-cells as defined via BCR-related markers with further characterization by additional markers. We observed heterogeneous phenotypes associated with more than one B-cell maturation pathway, particularly for the preB-I and preB-II stages in which V(D)J recombination takes place, with asynchronous marker expression patterns. Next Generation Sequencing of complete IGH gene rearrangements in sorted BCP subsets unraveled their rearrangement status, indicating that BCP differentiation does not follow a single linear pathway. In conclusion, B-cell development in human BM is not a linear process, but a rather complex network of parallel pathways dictated by V(D)J-recombination-driven checkpoints and pre-BCR/BCR mediated-signaling occurring during B-cell production and selection. It can also be described as asynchronous, because precursor B-cells do not differentiate as full population between the different stages, but rather transit as a continuum, which seems influenced (in part) by V-D-J recombination-driven checkpoints.
650    _2
$a buněčná diferenciace $x genetika $x imunologie $7 D002454
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a průtoková cytometrie $x metody $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a těžké řetězce imunoglobulinů $x genetika $7 D007143
650    _2
$a syndromy imunologické nedostatečnosti $x genetika $x imunologie $7 D007153
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prekurzorové B-lymfoidní buňky $x imunologie $7 D054448
650    _2
$a receptory antigenů B-buněk $x genetika $x imunologie $7 D011947
650    _2
$a V(D)J rekombinace $x genetika $x imunologie $7 D060152
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kalina, Tomas $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.
700    1_
$a Perez-Andres, Martin $u Department of Medicine-Service Cytometry, Cancer Research Center (IBMCC-CSIC/USAL) and University of Salamanca, Salamanca, Spain.
700    1_
$a Del Pino Molina, Lucia $u Department of Clinical Immunology, La Paz University Hospital, Lymphocyte Pathophysiology in Immunodeficiencies Group La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
700    1_
$a IJspeert, Hanna $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
700    1_
$a Kavelaars, François G $u Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
700    1_
$a Lankester, Arjan C $u Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
700    1_
$a Lecrevisse, Quentin $u Department of Medicine-Service Cytometry, Cancer Research Center (IBMCC-CSIC/USAL) and University of Salamanca, Salamanca, Spain.
700    1_
$a van Dongen, Jacques J M $u Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
700    1_
$a Orfao, Alberto $u Department of Medicine-Service Cytometry, Cancer Research Center (IBMCC-CSIC/USAL) and University of Salamanca, Salamanca, Spain.
700    1_
$a van der Burg, Mirjam $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands. Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands.
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 10, č. - (2019), s. 2680
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31849931 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154932 $b ABA008
999    __
$a ok $b bmc $g 1609077 $s 1119922
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 10 $c - $d 2680 $e 20191126 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace